BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3753642)

  • 1. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
    Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
    Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of VEPA and ACOMEP-BD regimen for the patients with non-Hodgkin's lymphoma].
    Kanamori H; Tanabe J; Okamoto R; Tamura T; Fujita H; Murata T; Hashimoto Y; Harano H; Matsuzaki M; Motomura S
    Rinsho Ketsueki; 1993 Jun; 34(6):697-704. PubMed ID: 8366571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Chubachi A; Miura AB; Yamaguchi A; Nishimura S
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
    Niitsu H; Fukuda M; Fukuda S; Takatsu H; Nakayama Y; Hirokawa M; Mamiya S; Miura I; Takahashi F; Yoshida K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2585-9. PubMed ID: 6594975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)].
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):323-9. PubMed ID: 6897859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VEPA therapy in B-lymphoma].
    Shimoyama M; Minato K; Takenaka T; Tobinai K; Seki S; Inaba S; Kitahara T; Konda C; Watanabe S
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):435-42. PubMed ID: 3485401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
    Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma].
    Ishige K; Matsue K; Tsukuda K; Sakai C; Takagi T
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2037-40. PubMed ID: 1417012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
    Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
    Tada A; Ohnoshi T; Hayashi K; Ueoka H; Ueno K; Murashima M; Mizuta J; Yoshida M; Kimura I
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2692-6. PubMed ID: 2443077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total gastrectomy after VEPA therapy in a case of primary gastric lymphoma (stage III of Naqvi's clinical staging)].
    Ishiguro T; Furumi K; Mukunoki Y; Nakamoto K; Hatano Y; Ookubo S; Matsuoka T
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3461-5. PubMed ID: 2802640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction polychemotherapy of non-Hodgkin's lymphomas in children].
    Radulesku GG; Kolygin BA
    Vopr Onkol; 1984; 30(6):33-7. PubMed ID: 6547553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
    Yamazaki H; Kuraishi Y; Takasaki N; Ozeki H; Mashizu N; Nagamine D; Usui N; Nakamura T; Aiba K; Yokoyama K
    Rinsho Ketsueki; 1985 Dec; 26(12):1936-41. PubMed ID: 2422407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvant chemotherapy for extranodal non-Hodgkin's lymphoma].
    Kuraishi Y; Nagamine D; Usui N; Yamazaki H; Nakamura T; Aiba K; Yokoyama K; Nagata T; Kobayashi A; Ikeda K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2545-9. PubMed ID: 6651308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group.
    Cancer Treat Rep; 1986 Aug; 70(8):985-90. PubMed ID: 2873890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.